Inventor · disambiguated record
Gavin Milne
Also filed as: MILNE GAVIN
1 granted patent·6 pending applications·0 citations·filing 2018–2023
1Inventor score
Top patents by PatentIndex Score
7 records- 0154US2025304574A13,4,6,7-tetrahydro-2,7-naphthyridine-2(1h)-carboxamide derivatives as gpr65 inhibitors for the treatment of cancer and autoimmune diseasesPATHIOS THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0251US2024368173A1Tricyclic gpr65 modulatorsPATHIOS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0351US2024228494A1CompoundsPATHIOS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0446US2023373989A1N-phenylaminocarbonyl pyridino-, pyrimidino and benzo-tropanes as modulators of gpr65PATHIOS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0546US2024051961A1N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds as gpr65 modulators for the treatment of cancerPATHIOS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0643US2023174530A1N-(phenylaminocarbonyl) tetrahydro-isoquinolines and related compounds as modulators of gpr65PATHIOS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0728US11220483B2Tetrahydro-benzo[d]azepine derivatives as GPR120 modulatorsCALDAN THERAPEUTICS LTD·Filed 2018·Granted Jan 11, 2022·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Gavin Milne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →